Quotes 5-day view Delayed Nasdaq
21 230 Volume
Estimated financial data (e) (USD)
Net income 2022
Net Debt 2022
P/E ratio 2022
Net income 2023
Net Debt 2023
P/E ratio 2023
Capi. / Sales 2022
Capi. / Sales 2023
Nbr of Employees
Dare Bioscience, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on advancing products for womenâ€™s health. Its portfolio of differentiated therapies expands treatment options, improve outcomes and facilitate convenience for women, primarily in the areas of contraception, vaginal health, sexual health and fertility. Its product pipeline includes three product candidates in advanced stages...
Ratings of Daré Bioscience, Inc.
All news about DARÉ BIOSCIENCE, INC.
11/16 Dare Bioscience Announces Grant to Develop Novel Hydrogel Formulation for Delivery of L..
11/15 Daré Bioscience Announces Grant to Develop Novel Hydrogel Formulation for Delivery of L..
11/14 Dare Bioscience, Inc. : Regulation FD Disclosure, Other Events, Financial Statements and E..
11/14 Daré Bioscience Announces Positive Topline Results from DARE-VVA1 Phase 1/2 Clinical St..
11/14 Daré Bioscience, Inc. Announces Positive Topline Results from DARE-VVA1 Phase 1/2 Clini..
11/10 Transcript : Daré Bioscience, Inc., Q3 2022 Earnings Call, Nov 10, 2022
11/10 DARE BIOSCIENCE, INC. Management's Discussion and Analysis of Financial Condition and ..
11/10 Daré Bioscience, Inc. Reports Earnings Results for the Third Quarter and Nine Months En..
11/10 Earnings Flash (DARE) DARE BIOSCIENCE Reports Q3 Loss $-0.08
11/10 Daré Bioscience Reports Third Quarter 2022 Financial Results and Provides a Company Upd..
11/08 Daré Bioscience to Present at the Stifel 2022 Healthcare Conference
11/03 Dare Bioscience, Inc. : Regulation FD Disclosure, Financial Statements and Exhibits (form ..
11/03 Daré Bioscience to Host Third Quarter 2022 Financial Results and Company Update Confere..
11/01 Daré Bioscience Announces Subject Screening for Phase 2b RESPOND Study of Sildenafil Cr..
11/01 Daré Bioscience Announces Subject Screening for Phase 2B Respond Study of Sildenafil Cr..
News in other languages on DARÉ BIOSCIENCE, INC.
Analyst Recommendations on DARÉ BIOSCIENCE, INC.
Chart DARÉ BIOSCIENCE, INC.
Technical analysis trends DARÉ BIOSCIENCE, INC.
Short Term Mid-Term Long Term Trends Neutral Bearish Bearish
Number of Analysts
Last Close Price
Average target price
Spread / Average Target